Defibrotide Clinical Trials
3 recruitingDrug
Phase 23
Showing 1–3 of 3 trials
Recruiting
Phase 2
Defibrotide Dose-escalation for SOS Post-HSCT
Sinusoidal Obstruction SyndromeVeno-occlusive Disease
New York Medical College20 enrolled1 locationNCT05987124
Recruiting
Phase 2
Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
Sickle Cell Disease
New York Medical College40 enrolled4 locationsNCT02675959
Recruiting
Phase 2
Defibrotide for the Treatment of Severe COVID-19
COVID19
Brigham and Women's Hospital42 enrolled1 locationNCT04652115